Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Firmly committed to curing vitiligo, the Vitiligo Research Foundation is a registered 501(c)3 non-profit organization, funding and fast-tracking medical research globally. Our mission is to develop effective treatments for millions of people around the world who suffer from vitiligo.
The foundation was born from the determination of one man - Dmitry Aksenov - to help his daughter, who was diagnosed with this debilitating skin disease at an early age.
After years of trying, and failing, to find an effective treatment for his daughter Dmitry realized something was wrong as vitiligo wasn’t getting the attention it deserved from the research community, because the money was not there to support projects.
Determined to change this, Dmitry decided to take up the fight himself and established the Vitiligo Research Foundation in 2010 – a non-profit organization with a remit to transcend national borders by funding and instigating vitiligo research across the world.
Mr. Aksenov had for many years donated to a variety of social and humanitarian causes – but the establishment of the VR Foundation was his first major contribution to the field of medical research. Working with the top specialists in the field, Dmitry has seen how researchers are trying diligently to unlock the secrets of this skin disease.
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- Can chemicals cause vitiligo?
It’s important to remember there are multiple factors involved in vitiligo onset, including genetic predisposition, living and working environments, and exposure to certain chem...
- Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials for vitiligo, in combination with narrowband UVB. The new drug acts as an anti-oxidant and activates melanin i...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.